Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 90
- 试验地点
- 2
- 主要终点
- Change from baseline in Pain Scores on the Visual Analog Scale at 12 Weeks
研究概览
简要总结
The investigators do research on chronic pain treatment to minimize the risks associated with opioids.
详细描述
The investigators know that patients suffering from chronic pain need good treatment. The use of opioids for chronic, non-cancer related pain may seem appropriate in the short term, but can often have negative consequences for both the individual and society in the long term.
Several factors-the escalating use of opioids to chronic pain patients, the increasing use of strong opioids in particular, and the increasing number of overdoses caused by prescription opioids-point to the start of an opioid epidemic in Norway.
Objectives The overall goal of the POINT project is to provide knowledge to optimize treatment of patients with chronic pain in order to avoid unnecessary escalation of opioid treatment, improve their quality of life and reduce the burden of disease.
In the long run our objective is to prevent the unwanted consequences of opioid treatment and improve patients' quality of life.
Ultimately, through this project the investigators hope to prevent an opioid epidemic in Norway.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Sequential
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 67 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •non-malignant, chronic pain
- •Registered in Stavanger municipality
- •Consent to participation.
- •Age 18 - 67 years
- •Pain duration <10 years
排除标准
- •malignant pain condition
结局指标
主要结局
Change from baseline in Pain Scores on the Visual Analog Scale at 12 Weeks
时间窗: 12 weeks
Visual Analog Scale
Change from baseline in Bergen Insomnia scale at 12 Weeks
时间窗: 12 weeks
BIS
Change From Baseline in Audit C at 12 Weeks
时间窗: 12 weeks
Audit C
Change from baseline in Health-related quality of life at 12 Weeks
时间窗: 12 weeks
HQ5D5L
次要结局
未报告次要终点
研究者
Kine Gjesdal
Associate professor
Helse Stavanger HF